2020
DOI: 10.1186/s13046-019-1489-0
|View full text |Cite
|
Sign up to set email alerts
|

Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression

Abstract: Background: Mps1 binding protein (MOB1) is one of the core components of the mammalian Hippo pathway and plays important roles in cancer development. However, its expression, function and regulation in pancreatic ductal adenocarcinoma (PDAC) have not been revealed yet. Methods: The expression of MOB1 and lysine demethylase 2B (KDM2B) in PDAC and adjacent normal pancreas tissues were measured. Also, the underlying mechanisms of altered MOB1 expression and its impact on PDAC biology were investigated. Results: W… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
15
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 49 publications
(80 reference statements)
1
15
2
Order By: Relevance
“…In accordance to our results, the mRNA expression of MOB3B is significantly lower in PCa tissues than in healthy control tissues, which is further closely associated with aggressive pathophysiological features in patients with PCa [21]. By directly binding to the promoter region of MOB1, KDM2B has been demonstrated to suppress the promoter activity of MOB1 and transcriptionally inhibit MOB1 expression, thus augmenting the proliferation, migration and invasion of pancreatic ductal adenocarcinoma cells [22], which is partially in consistent with our results. Furthermore, in the response of both PC3 cell line and nude mice to KDM5A overexpression, the mRNA and protein levels of YTHDF2 was found to be significantly downregulated.…”
Section: Discussionsupporting
confidence: 92%
“…In accordance to our results, the mRNA expression of MOB3B is significantly lower in PCa tissues than in healthy control tissues, which is further closely associated with aggressive pathophysiological features in patients with PCa [21]. By directly binding to the promoter region of MOB1, KDM2B has been demonstrated to suppress the promoter activity of MOB1 and transcriptionally inhibit MOB1 expression, thus augmenting the proliferation, migration and invasion of pancreatic ductal adenocarcinoma cells [22], which is partially in consistent with our results. Furthermore, in the response of both PC3 cell line and nude mice to KDM5A overexpression, the mRNA and protein levels of YTHDF2 was found to be significantly downregulated.…”
Section: Discussionsupporting
confidence: 92%
“…36 In another study of pancreatic ductal adenocarcinoma, lysine demethylase 2 (KDM2B) suppressed the expression of MOB1 by its binding to the promoter region of MOB1, then YAP-mediated transcription promoted the invasion, migration and proliferation of cancer cells. 37 Contrary to these reports, in our study MOB1 increased the migration ability of cancer cells. Our microarray results suggest that MOB1 in NSCLC could predominantly regulate the expression of genes promoting cancer invasiveness such as MCAM and ADAM12.…”
Section: Discussioncontrasting
confidence: 99%
“…In hepatocellular carcinoma, MOB2 negatively regulates phosphorylation of MOB1 and LATS which could lead to YAP activation and increased motility of cancer cells 36 . In another study of pancreatic ductal adenocarcinoma, lysine demethylase 2 (KDM2B) suppressed the expression of MOB1 by its binding to the promoter region of MOB1, then YAP‐mediated transcription promoted the invasion, migration and proliferation of cancer cells 37 . Contrary to these reports, in our study MOB1 increased the migration ability of cancer cells.…”
Section: Discussioncontrasting
confidence: 91%
“…Data on transcriptional regulation of Mob genes is scarce, but alteration of DNA methylation patterns has been proposed as a possible mechanism to affect regulation of the levels of MOB proteins and is often associated to cancer. Studies of DNA methylation patterns revealed that lysine demethylase 2B (KDM2B) directly bound to the promoter region of HsMob1 gene, inhibited and promoted pancreatic ductal adenocarcinoma progression [84]. Furthermore, in a study concerning methylation in human breast cancer in response to resveratrol, HsMOB1 promotor presented methylation changes in triple-negative breast cancer cells [85].…”
Section: Transcriptional and Post-transcriptional Regulation Of Mobsmentioning
confidence: 99%